Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Mesothelial

Explore clinical trials studying Neoplasms, Mesothelial. Study availability and eligibility vary by location and protocol.

370 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Mesothelial trial results

Completed

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

NCT02709512

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UCLA Hematology & Oncology - Santa Monica Los Angeles, California, United States
  • University of California San Francisco Helen Diller Comprehensive Cancer Center San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
View all 45 locations
View Trial Details
Completed

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

NCT01486368

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

NCT02899195

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University San Diego Moores Cancer Center La Jolla, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 20 locations
View Trial Details
Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

NCT00101283

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 115 locations
View Trial Details
Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

NCT03507452

Conditions
Adenoma, Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated), Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, +15 more
Locations
  • National Cancer Institute - Maryland Bethesda, Maryland, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • HUS, Meilahden sairaala Helsinki, Finland
  • Nederlands Kanker Instituut Amsterdam, Netherlands
View Trial Details

Related conditions